Lung Expansion Therapy



Lung Expansion Therapy







Treating and preventing atelectasis, the collapse of distal lung parenchyma, should always be a main concern of a respiratory therapist (RT), especially when dealing with postoperative and bedridden patients. Correct therapy must be implemented early before atelectasis leads to deterioration of the patient’s pulmonary status. A patient’s medical history should provide the RT with the first indication that atelectasis may be present. Clinical signs of atelectasis, when recognized, often indicate considerable pulmonary involvement. Boxes 16-1 and 16-2 list these signs and chest radiography findings, which help confirm the presence of atelectasis. If the atelectasis becomes significant, hypoxemia may manifest clinically with tachycardia. Respiratory therapists must be vigilant in their assessments of patients to ensure that even the subtlest signs are not overlooked.




In the hospital setting, patients capable of ambulation will be assisted out of bed and encouraged to walk. This exercise has a dramatic influence and facilitates improvement in their pulmonary status. In cases with suspected or confirmed atelectasis, additional lung expansion modalities may also be supplemented to a patient’s treatment regimen.


This chapter will discuss the concept of lung expansion and includes incentive spirometry (IS) and intermittent positive pressure breathing (IPPB) therapies. Understanding clinical signs and identifying patients at risk for developing atelectasis are also discussed.



» Skill Check Lists


16-1 Performing Incentive Spirometry


IS is used to treat and prevent atelectasis. Devices, illustrated in Figure 16-1, may be flow-oriented devices, which measure and visually indicate the inspiratory flow and equate it with volume, or volume-oriented devices, which measure and indicate visually the volume the patient is achieving during a sustained maximal inspiration (SMI). To attain a SMI, the patient must breathe in slowly and deeply to total lung capacity (TLC) and then hold the breath for about 5 to 10 seconds. A comparison of alveolar and pleural pressure changes during a normal, spontaneous breath and during an SMI are illustrated in Figure 16-2.




Success and beneficial outcomes with IS are dependent on competent instruction regarding the use of the device.



Box 16-3 lists the assessment tools and monitoring parameters that help evaluate a patient’s performance with the IS device.



The following is the step-by-step process for the use of incentive spirometry.







16-2 Performing Intermittent Positive Pressure Breathing


IPPB is a treatment modality in which inspiratory positive pressure is applied to the airway of a spontaneously breathing patient on a short-term basis, usually lasting about 15 minutes per treatment to treat atelectasis. Figure 16-3 illustrates pressure changes during spontaneous breathing compared with IPPB.



In the past, IPPB was a widely accepted and commonly implemented therapy used for lung expansion by RTs. However, with little evidence of benefit for many patients and increasing cost-consciousness in respiratory departments, the use of IPPB has diminished. The American Association for Respiratory Care (AARC) has established comprehensive guidelines for the use of IPPB therapy.



Patients selected for IPPB therapy must be carefully chosen and the indications for therapy and goals clearly understood. Troubleshooting the machine is important to ensure the best patient outcomes. The chart in Figure 16-4 illustrates some common problems and how to correct them. When determining the effectiveness of the therapy, the RT should evaluate for improved breath sounds, increased tidal volume by 25%, and an increase in the vital capacity to 15 mL/kg. The following is the step-by-step process for the use of IPPB as a lung expansion therapy.






Implementation




1. Place the patient in the semi-Fowler position, and instruct the patient to breathe normally.


2. Assess vital signs.


3. Obtain baseline values for inspiratory capacity, expiratory tidal volume, and peak expiratory flow rate.


4. Check machine sensitivity:



5. Check the machine and circuit for leaks:



6. Instruct the patient on how to breathe correctly:



7. Adjust the machine as required by the patient’s ventilatory patterns:



8. Monitor inspiratory capacity, respiratory rate, heart rate, and blood pressure midway through the procedure.


9. Encourage the patient to cough.


10. Reassess vital signs.


11. Remove the supplies from the patient’s room, and clean the area, as needed.


12. Remove PPE, and perform proper hand hygiene prior to leaving the patient’s room.





16-3 Administering EzPAP


Another device used for lung expansion therapy to aid in the treatment and prevention of atelectasis is EzPAP Positive Airway Pressure System (Smiths Medical, Norwell, MA) (Figure 16-5). It is often used when a patient has difficulties with incentive spirometry. It may be administered using a mouthpiece or a mask, and it allows for the addition of an in-line nebulizer during use. Positive airway pressure is produced via a flowmeter, using oxygen or air, throughout the patient’s breathing cycle. The following is the step-by-step process for the use of EzPAP.



Stay updated, free articles. Join our Telegram channel

Jun 12, 2016 | Posted by in RESPIRATORY | Comments Off on Lung Expansion Therapy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access